| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Payment of offering costs associated with the sales agreement | 100,000 | - |
| Proceeds from issuance of shares under the sales agreement, net of offering costs | 3,101,409 | - |
| Proceeds from loan agreement | 3,400,000 | - |
| Net cash provided by financing activities | 9,901,409 | 5,900,000 |
| Net (decrease) increase in cash | -245,901 | -597,766 |
| Cash and cash equivalents at beginning of period | 1,282,995 | - |
| Cash and cash equivalents at end of period | 1,037,094 | - |
Tevogen Bio Holdings Inc. (TVGNW)
Tevogen Bio Holdings Inc. (TVGNW)